KL003 cell injection Drug Product
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Institute of Hematology & Blood Diseases Hospital, China
Overview
KL003 cell injection Drug Product is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
KL003 cell injection Drug Product clinical trials
Explore related
Medical disclaimer. This page summarizes research about KL003 cell injection Drug Product for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.